EU Adviser Backs Antitrust Fine for AstraZeneca

15.05.2012 - AstraZeneca misled patent regulators more than a decade ago in a bid to block competition to its ulcer drug Losec, an adviser to Europe's top court said on Tuesday, backing a €52.5...